Press releasePRNewswire
cbdMD
YCBD · NYSE American
$0.3873+$0.0392 (+11.26%)TodayMarket closed ·
Prev close $0.3481
Latest news
- Press releasePRNewswire
cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness
- News
cbdMD Q3 2026 Earnings Call: Complete Transcript
- Press releasePRNewswire
cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026
- Press releasePRNewswire
cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results
- Press releasePRNewswire
cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Press releasePRNewswire
cbdMD Supports the Bipartisan Lawful Hemp Protection Act to Protect Consumers and Full-Spectrum CBD Access
- Press releasePRNewswire
cbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina
- Press releasePRNewswire
cbdMD's Bluebird Botanicals Announces Official Partnership With Denver Audubon to Support Bird Conservation
- Press releasePRNewswire
cbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS Determination
- Press releasePRNewswire
Oasis Launches Hemp-Derived Mixer
- Press releasePRNewswire
cbdMD Welcomes White House Call for Fair Treatment of Hemp-Derived Products
- Press releasePRNewswire
cbdMD Appoints Wade Brown Chief Marketing Officer
- News
Full Transcript: cbdMD Q2 2026 Earnings Call
- Press releasePRNewswire
cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum
- News
Earnings Scheduled For May 14, 2026
- Press releasePRNewswire
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results
- Press releaseBusiness Wire
Hawkeye Systems Announces New Board Members With Deep Capital Markets, Governance, Legal, and Merchant Banking Experience
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Why United Rentals Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
- Press releasePRNewswire
cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare
- Press releasePRNewswire
cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026
- News
Earnings Outlook For cbdMD
- Press releasePRNewswire
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results
- Press releasePRNewswire
cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum
- Press releasePRNewswire
cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways
- Press releasePRNewswire
cbdMD Announces Strategic Acquisition of Bluebird Botanicals
- NewsRishabh Mishra
Stock Market Today: Dow Jones, S&P 500 Futures Climb At The Start Of Christmas Week— Kemper, Trump Media & Technology, cbdMD In Focus (UPDATED)
- Press releasePRNewswire
cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance
- Press releasePRNewswire
cbdMD, Inc. Announces Closing of $2.25 Million Series C Preferred Stock Private Placement
- News
cbdMD Shares Halted, News Pending
- NewsAvi Kapoor
Why Oracle Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
- Press releaseNewsfile
cbdMD Generates $4.6 Million of Revenue for the 3rd Quarter
- Press releaseNewsfile
cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter
- Press releaseNewsfile
cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting
- Press releaseNewsfile
cbdMD Generates $5.1 Million in Revenue, Positive Earnings
- Press releaseNewsfile
cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement
- Press releaseNewsfile
cbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.